Medication | Addiction Professional Magazine Skip to content Skip to navigation

Medication

Three keys to lowering mortality rates in opioid disorder patients

July 21, 2017  |  Alison Knopf, Contributing Writer
article
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.

ADHD patients' substance use risk lower in medicated periods

July 17, 2017  |  Gary A. Enos, Editor
news
Researchers have found that individuals with attention-deficit/hyperactivity disorder (ADHD) are at lower risk of alcohol or drug abuse when they are taking ADHD medications.

Partnership in R.I. will accelerate buprenorphine training

July 13, 2017  |  Gary A. Enos, Editor
article
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.

Outstanding Clinical Care Award: Stanley Street Treatment and Resources Opioid Triage Center

July 12, 2017  |  Gary A. Enos, Editor
article
Individuals affected by the opioid crisis are benefiting from an expansion of SSTAR's open-access model of service.

Drug maker agrees to stop selling Opana ER because of misuse

July 7, 2017  |  Julie Miller, Editor in Chief
news
Endo Pharmaceuticals on Thursday agreed to remove its long-acting Opana ER pain drug from the market, following an FDA request that it stop selling the product because of incidents of misuse.

Place medication in the rightful context

June 27, 2017  |  Gary A. Enos, Editor
blog
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.

Few young people with opioid dependence have received medication

June 21, 2017  |  Gary A. Enos, Editor
news
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.

AATOD leader among Faces & Voices honorees

June 20, 2017  |  Gary A. Enos, Editor
news
Mark Parrino of the American Association for the Treatment of Opioid Dependence (AATOD) will receive the Lisa Mojer-Torres Award next month from Faces & Voices of Recovery.

Research will apply technology to improve buprenorphine compliance

June 20, 2017  |  Gary A. Enos, Editor
article
The National Institute on Drug Abuse (NIDA) is funding a study that will determine whether direct observation of patients receiving buprenorphine treatment can improve retention in treatment and drug use outcomes.

NIH, private partners team up on opioid crisis initiative

June 19, 2017  |  Tom Valentino, Senior Editor
article
The National Institutes of Health (NIH) has announced a partnership with private entities on a three-faceted scientific initiative to address the opioid crisis.

Faces & Voices will honor researcher Kreek

June 15, 2017  |  Gary A. Enos, Editor
news
Mary Jeanne Kreek, MD, whose research helped lead to the development of methadone maintenance treatment, will receive a lifetime achievement award from Faces & Voices of Recovery next month.

Predictive testing company under fraud investigation

June 12, 2017  |  Gary A. Enos, Editor
news
Proove Biosciences, which markets technology designed to predict a patient's response to opioid dependence medications and other drugs, has had its office headquarters raided in an apparent healthcare fraud probe.

Pages

Subscribe to Medication